Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Nectin-4 ADC, Urothelial Cancer

Andrea Necchi

MD

🏢IRCCS San Raffaele Hospital🌐Italy

Director of Genitourinary Oncology

55
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Dr. Andrea Necchi is Italy's foremost bladder cancer specialist and a European leader in urothelial carcinoma research. He has contributed to European cohort studies of enfortumab vedotin and is a principal investigator in multiple urothelial cancer trials. His research spans neoadjuvant therapy, bladder preservation, and novel systemic therapies including ADCs for urothelial malignancies.

Share:

🧪Research Fields 研究领域

enfortumab vedotin Europe
urothelial ADC Italian cohorts
neoadjuvant therapy bladder cancer
muscle-invasive bladder cancer
bladder preservation strategies

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Andrea Necchi 的研究动态

Follow Andrea Necchi's research updates

留下邮箱,当我们发布与 Andrea Necchi(IRCCS San Raffaele Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment